Oxygen in Wound Healing: Hypoxia, HBO, and Clinical Impact

Oxygen in Wound Healing: Why Tissue Oxygenation Determines Outcomes

Oxygen is not a supplement to wound healing — it is a substrate. Every energy-dependent cellular process in wound repair requires oxygen: collagen synthesis, angiogenesis, bacterial killing by neutrophils, epithelial cell migration, and extracellular matrix assembly. When tissue oxygen levels fall below the threshold needed to support these processes, wounds stall regardless of what dressings, growth factors, or advanced therapies are applied. Understanding how oxygen functions in wound healing, how to assess tissue oxygenation, and when supplemental oxygen therapy changes outcomes is essential for every wound care clinician.

How Oxygen Functions in Wound Repair

Collagen Synthesis and Cross-Linking

Collagen is the primary structural protein in wound repair. Its synthesis requires hydroxylation of proline and lysine residues by prolyl hydroxylase and lysyl hydroxylase — enzymes that are strictly oxygen-dependent. The Km (half-maximal activity) of prolyl hydroxylase for oxygen is approximately 25 mmHg, meaning that collagen synthesis drops sharply when tissue oxygen tension falls below this threshold. Without adequate oxygen, fibroblasts produce structurally deficient collagen that lacks the tensile strength needed for durable wound closure.

Oxidative Bacterial Killing

Neutrophils kill bacteria primarily through the respiratory burst — an NADPH oxidase-driven reaction that produces superoxide, hydrogen peroxide, and hypochlorous acid. This reaction consumes oxygen at rates 10 to 20 times the resting rate. When tissue oxygen is low, the respiratory burst is impaired, and bacterial killing capacity drops proportionally. This is why hypoxic wounds are prone to infection even when the immune system is otherwise competent and why infection control in ischemic wounds is disproportionately difficult.

Angiogenesis Signaling

Paradoxically, hypoxia is both a driver and an obstacle in wound healing. Moderate hypoxia at the wound center stabilizes HIF-1alpha, which upregulates VEGF and stimulates new vessel formation. However, severe or prolonged hypoxia — as seen in peripheral artery disease — overwhelms this adaptive response. Endothelial cells cannot proliferate without oxygen, so the angiogenic signal (VEGF) is produced but the vessels cannot be built. This creates the clinical picture of a wound that generates exudate and inflammatory tissue but produces no functional granulation.

Epithelialization

Keratinocyte migration and proliferation are oxygen-dependent processes. Adequate oxygen at the wound surface supports the ATP production needed for cellular migration. Under conditions of chronic hypoxia, keratinocytes at the wound edge become quiescent, and epithelialization slows or stops.

Causes of Wound Hypoxia

Macrovascular Disease

Peripheral artery disease is the most common cause of clinically significant wound hypoxia. Arterial stenosis or occlusion reduces the volume of oxygenated blood reaching the wound bed. In critical limb ischemia (CLI), tissue oxygen levels may be insufficient to support any meaningful wound healing. Vascular assessment and revascularization consideration are foundational in these patients. See our guide on peripheral artery disease and wound care.

Microvascular Disease

Diabetes, chronic kidney disease, and autoimmune vasculitis damage small vessels and capillaries. Even when macrovascular flow is adequate, microvascular dysfunction limits oxygen delivery to the tissue level. Diabetic microangiopathy is particularly insidious because it may not be detectable by standard ABI or pulse examination.

Increased Oxygen Demand

Infected wounds and wounds with high bacterial bioburden consume oxygen at elevated rates. Bacterial metabolism and the neutrophil respiratory burst compete with wound repair cells for available oxygen. The result is a wound that may have adequate perfusion but still experiences functional hypoxia because oxygen consumption exceeds delivery.

Edema and Tissue Compression

Edema increases the diffusion distance for oxygen between capillaries and cells. In venous leg ulcers, chronic edema, fibrin cuff formation around capillaries, and interstitial fluid accumulation all impair oxygen diffusion despite adequate arterial supply. Compression therapy addresses this by reducing edema and restoring a functional diffusion distance.

Smoking

Carbon monoxide from cigarette smoke binds hemoglobin with 200-250 times the affinity of oxygen, producing carboxyhemoglobin that cannot deliver oxygen to tissues. Nicotine simultaneously causes vasoconstriction, compounding the oxygen delivery deficit. The combined effect is measurable: smokers have significantly lower transcutaneous oxygen levels at wound sites than nonsmokers with equivalent vascular anatomy.

Assessing Tissue Oxygenation

Transcutaneous Oxygen Measurement (TcPO2)

TcPO2 is the most direct clinical measurement of tissue oxygenation at the wound site. A heated sensor placed on periwound skin measures the partial pressure of oxygen diffusing through the skin surface.

Interpretation thresholds:

TcPO2 >40 mmHg: Adequate healing potential. Most wounds with this oxygen level will heal with appropriate local wound care.
TcPO2 20-40 mmHg: Borderline. Healing is possible but may be slow or require advanced interventions.
TcPO2 <20 mmHg: Severely impaired healing potential. Wounds at this oxygen level are unlikely to heal without vascular intervention or supplemental oxygen therapy.

TcPO2 also serves as a predictor of hyperbaric oxygen (HBO) response: patients who demonstrate a significant TcPO2 increase during HBO challenge testing (breathing 100% oxygen) are more likely to benefit from a full HBO treatment course.

Ankle-Brachial Index

ABI provides an indirect assessment of macrovascular perfusion but does not directly measure tissue oxygenation. An ABI <0.5 strongly correlates with inadequate tissue oxygenation. An ABI >1.3 in diabetic patients suggests calcified vessels that may produce falsely elevated readings.

Clinical Assessment

Wound bed color remains a useful indicator: beefy red granulation suggests adequate oxygenation; pale, gray, or dusky tissue suggests ischemia. However, clinical observation alone cannot distinguish moderate from severe hypoxia or predict healing trajectory with the precision needed for treatment decisions.

Hyperbaric Oxygen Therapy in Wound Care

Mechanism of Action

HBO therapy delivers 100% oxygen at pressures greater than atmospheric (typically 2.0-2.4 ATA). This dramatically increases dissolved plasma oxygen — from approximately 3 mL/L at atmospheric pressure to 60 mL/L at 2.4 ATA. This dissolved oxygen bypasses hemoglobin entirely, diffusing directly from plasma into tissues regardless of microvascular disease or hemoglobin dysfunction.

HBO also produces secondary effects: it stimulates VEGF production, promotes stem cell mobilization from bone marrow, enhances neutrophil bacterial killing, and reduces edema through vasoconstriction that does not reduce net oxygen delivery (because the increase in dissolved oxygen more than compensates for reduced flow).

Evidence-Based Indications

HBO is indicated for specific wound types with supporting evidence:

Diabetic foot ulcers (Wagner grade 3 or higher) that have failed standard wound care for 30 days
Compromised skin grafts and flaps
Chronic refractory osteomyelitis
Delayed radiation injury (soft tissue and bone)
Crush injuries and compartment syndromes

For detailed referral criteria and patient selection considerations, see our hyperbaric oxygen referral guide.

What HBO Does Not Do

HBO does not replace vascular intervention in patients with correctable macrovascular disease. It does not overcome inadequate wound bed preparation. It does not work for wounds that have other unaddressed barriers — uncontrolled diabetes, malnutrition, continued pressure, or untreated infection. HBO is adjunctive therapy, not primary therapy, and patient selection determines its clinical value.

Topical Oxygen Therapy

Topical oxygen therapy (TOT) delivers oxygen directly to the wound surface at or near atmospheric pressure. Continuous diffusion topical oxygen therapy devices provide a low-flow continuous delivery of oxygen to the wound bed through a cannula connected to a small portable oxygen concentrator.

The evidence base for TOT is growing but less established than for HBO. It may offer a more accessible option for patients who cannot tolerate or access HBO chambers, but it should not be considered equivalent to HBO for the indications where HBO has strong evidence.

Key Takeaways

Oxygen is a required substrate for collagen synthesis, bacterial killing, angiogenesis, and epithelialization — not an adjunct but a prerequisite for wound healing.
TcPO2 measurement directly quantifies tissue oxygenation: >40 mmHg indicates adequate healing potential, and <20 mmHg indicates severe impairment requiring vascular intervention or supplemental oxygen.
HBO therapy works by delivering dissolved plasma oxygen that bypasses hemoglobin and microvascular disease, but it is adjunctive therapy that requires appropriate patient selection.
Wound hypoxia has multiple causes — macrovascular disease, microvascular dysfunction, edema, increased oxygen consumption from infection, and smoking — and effective treatment requires identifying and addressing the specific cause.
Clinical observation of wound bed color correlates with oxygenation but cannot replace quantitative assessment for treatment decisions in chronic wounds.